10-K Filing

IMMIX BIOPHARMA, INC. CIK: 1873835 FY 2022

Filing Information

Form Type	10-K
Accession Number	`0001493152-23-009091`
Period End Date	20221231
Filing Date	20230327
Fiscal Year	2022
Fiscal Period	FY
XBRL Instance	form10-k_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 61 Income Statement 32 Cash Flow Statement 66 Stockholders Equity 23

Balance Sheet 61 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$13.44M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$17.64M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Tax receivable	`IncomeTaxReceivable`	$25.72K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Tax receivable	`IncomeTaxReceivable`	$255.71K	USD	Point-in-time
Common stock par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$516.19K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.21M	USD	Point-in-time
Common stock par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$18.19M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$14.90M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	-	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	13.96M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	13.23M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.72K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	13.23M	shares	Point-in-time
Equipment, net	`PropertyPlantAndEquipmentNet`	$5.70K	USD	Point-in-time
Equipment, net	`PropertyPlantAndEquipmentNet`	$3.56K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	13.89M	shares	Point-in-time
Treasury stock, shares	`TreasuryStockShares`	0.00	shares	Point-in-time
Total assets	`Assets`	$18.19M	USD	Point-in-time
Total assets	`Assets`	$14.91M	USD	Point-in-time
Treasury stock, shares	`TreasuryStockShares`	72,363.00	shares	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$142.94K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.27M	USD	Point-in-time
Accrued interest	`InterestPayableCurrent`	$9.10K	USD	Point-in-time
Accrued interest	`InterestPayableCurrent`	-	USD	Point-in-time
Note payable	`NotesPayableCurrent`	$50.00K	USD	Point-in-time
Note payable	`NotesPayableCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$202.04K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.27M	USD	Point-in-time
Funds held for subsidiary private offering	`FundsHeldForSubsidiaryPrivateOfferingNonCurrent`	-	USD	Point-in-time
Funds held for subsidiary private offering	`FundsHeldForSubsidiaryPrivateOfferingNonCurrent`	$475.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$1.75M	USD	Point-in-time
Total liabilities	`Liabilities`	$202.04K	USD	Point-in-time
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value; 200,000,000 shares authorized; 13,964,485 shares issued and 13,892,122 shares outstanding at December 31, 2022, and 13,228,689 shares issued and outstanding at December 31, 2021	`CommonStockValue`	$1.32K	USD	Point-in-time
Common stock, $0.0001 par value; 200,000,000 shares authorized; 13,964,485 shares issued and 13,892,122 shares outstanding at December 31, 2022, and 13,228,689 shares issued and outstanding at December 31, 2021	`CommonStockValue`	$1.40K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$51.16M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$47.62M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$87.02K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$125.41K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-29.76M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-37.99M	USD	Point-in-time
Treasury stock at cost, 72,363 and no shares as of December 31, 2022 and 2021, respectively	`TreasuryStockValue`	$99.96K	USD	Point-in-time
Treasury stock at cost, 72,363 and no shares as of December 31, 2022 and 2021, respectively	`TreasuryStockValue`	-	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-4.73M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.16M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$17.99M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$14.91M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$18.19M	USD	Point-in-time

Income Statement 32 line items

Line Item	Tag	Value	Unit	Period
General and administrative expenses	`GeneralAndAdministrativeExpense`	$4.02M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.23M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$126.53K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$4.20M	USD	Annual
Total operating expenses	`OperatingExpenses`	$8.22M	USD	Annual
Total operating expenses	`OperatingExpenses`	$1.35M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-1.35M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-8.22M	USD	Annual
Change in fair value of derivative liability	`DerivativeGainLossOnDerivativeNet`	-	USD	Annual
Change in fair value of derivative liability	`DerivativeGainLossOnDerivativeNet`	$-22.76M	USD	Annual
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-86.17K	USD	Annual
Interest expense	`InterestExpense`	$179.85K	USD	Annual
Interest expense	`InterestExpense`	$497.00	USD	Annual
Total other expense	`NonoperatingIncomeExpense`	$-23.03M	USD	Annual
Total other expense	`NonoperatingIncomeExpense`	$-497.00	USD	Annual
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-8.22M	USD	Annual
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-24.38M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$6.01K	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$10.27K	USD	Annual
Net loss	`ProfitLoss`	$-24.38M	USD	Annual
Net loss	`ProfitLoss`	$-8.23M	USD	Annual
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-6.45K	USD	Annual
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-38.39K	USD	Annual
Total other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-38.39K	USD	Annual
Total other comprehensive loss	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-6.45K	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-24.39M	USD	Annual
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-8.27M	USD	Annual
Loss per common share - basic and diluted	`EarningsPerShareBasic`	$-6.64	USD	Annual
Loss per common share - basic and diluted	`EarningsPerShareBasic`	$-0.59	USD	Annual
Weighted average shares outstanding basic and diluted	`WeightedAverageNumberOfSharesOutstandingBasic`	13.89M	shares	Annual
Weighted average shares outstanding basic and diluted	`WeightedAverageNumberOfSharesOutstandingBasic`	3.67M	shares	Annual

Cash Flow Statement 66 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-24.38M	USD	Annual
Net loss	`ProfitLoss`	$-8.23M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$218.98K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$524.07K	USD	Annual
Shares issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	Annual
Shares issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$100.00K	USD	Annual
Convertible note issued in exchange for services	`ConvertibleNoteIssuedInExchangeForServices`	-	USD	Annual
Convertible note issued in exchange for services	`ConvertibleNoteIssuedInExchangeForServices`	$60.00K	USD	Annual
Change in fair value of derivative liability	`DerivativeGainLossOnDerivativeNet`	-	USD	Annual
Change in fair value of derivative liability	`DerivativeGainLossOnDerivativeNet`	$-22.76M	USD	Annual
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-86.17K	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$58.16K	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	-	USD	Annual
Depreciation	`Depreciation`	$2.13K	USD	Annual
Depreciation	`Depreciation`	$2.47K	USD	Annual
Tax receivable	`IncreaseDecreaseInIncomeTaxesReceivable`	$236.38K	USD	Annual
Tax receivable	`IncreaseDecreaseInIncomeTaxesReceivable`	$-97.67K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$691.05K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$502.80K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$1.13M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-106.06K	USD	Annual
Accrued interest	`IncreaseDecreaseInInterestPayableNet`	$120.15K	USD	Annual
Accrued interest	`IncreaseDecreaseInInterestPayableNet`	$-9.10K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.59M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-7.41M	USD	Annual
Purchase of equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	Annual
Purchase of equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$802.00	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-802.00	USD	Annual
Payments of deferred offering costs	`PaymentOfFinancingAndStockIssuanceCosts`	-	USD	Annual
Payments of deferred offering costs	`PaymentOfFinancingAndStockIssuanceCosts`	$6.72K	USD	Annual
Proceeds from convertible notes payable	`ProceedsFromNotesPayable`	$200.00K	USD	Annual
Proceeds from convertible notes payable	`ProceedsFromNotesPayable`	-	USD	Annual
Payments on note payable	`RepaymentsOfNotesPayable`	-	USD	Annual
Payments on note payable	`RepaymentsOfNotesPayable`	$50.00K	USD	Annual
Proceeds from sale of common stock, net of offering costs	`ProceedsFromIssuanceOfCommonStock`	$18.65M	USD	Annual
Proceeds from sale of common stock, net of offering costs	`ProceedsFromIssuanceOfCommonStock`	$2.91M	USD	Annual
Funds received for subsidiary private offering	`ProceedsFromIssuanceOfPrivatePlacement`	-	USD	Annual
Funds received for subsidiary private offering	`ProceedsFromIssuanceOfPrivatePlacement`	$475.00K	USD	Annual
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$99.96K	USD	Annual
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.23M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$18.85M	USD	Annual
Effect of foreign currency on cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-31.52K	USD	Annual
Effect of foreign currency on cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-5.43K	USD	Annual
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$17.25M	USD	Annual
Net change in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-4.21M	USD	Annual
Cash - beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$17.64M	USD	Point-in-time
Cash - beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$13.44M	USD	Point-in-time
Cash - beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$391.09K	USD	Point-in-time
Cash - end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$17.64M	USD	Point-in-time
Cash - end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$13.44M	USD	Point-in-time
Cash - end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$391.09K	USD	Point-in-time
Interest paid	`InterestPaidNet`	$9.60K	USD	Annual
Interest paid	`InterestPaidNet`	$1.54K	USD	Annual
Income taxes paid	`IncomeTaxesPaidNet`	-	USD	Annual
Income taxes paid	`IncomeTaxesPaidNet`	-	USD	Annual
Relative fair value of warrants issued in connection with convertible debt	`RelativeFairValueOfWarrantsIssuedInConnectionWithConvertibleDebt`	-	USD	Annual
Relative fair value of warrants issued in connection with convertible debt	`RelativeFairValueOfWarrantsIssuedInConnectionWithConvertibleDebt`	$74.60K	USD	Annual
Debt discount related to derivative liabilities	`DebtDiscountRelatedToDerivativeLiabilities`	$80.00K	USD	Annual
Debt discount related to derivative liabilities	`DebtDiscountRelatedToDerivativeLiabilities`	-	USD	Annual
Common stock issued upon conversion of notes payable, related accrued interest and settlement of derivative liability	`StockIssued1`	-	USD	Annual
Common stock issued upon conversion of notes payable, related accrued interest and settlement of derivative liability	`StockIssued1`	$28.18M	USD	Annual
Cashless exercise of stock options	`CashlessExerciseOfStockOptions`	-	USD	Annual
Cashless exercise of stock options	`CashlessExerciseOfStockOptions`	$6.00	USD	Annual

Stockholders Equity 23 line items

Line Item	Tag	Value	Unit	Period
Beginning balance, value	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-4.73M	USD	Point-in-time
Beginning balance, value	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.16M	USD	Point-in-time
Beginning balance, value	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$17.99M	USD	Point-in-time
Shares issued for cash proceeds, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$18.65M	USD	Annual
Shares issued for cash proceeds, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$2.91M	USD	Annual
Begining balance, shares	`StockIssuedDuringPeriodSharesNewIssues`	5.00M	shares	Point-in-time
Shares issued for conversion of convertible notes payable, related accrued interest and settlement of derivative liability	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$28.17M	USD	Annual
Relative fair value of warrants issued in connection with debt	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$74.60K	USD	Annual
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$524.07K	USD	Annual
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$218.98K	USD	Annual
Net loss	`ProfitLoss`	$-24.38M	USD	Annual
Net loss	`ProfitLoss`	$-8.23M	USD	Annual
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax`	$-6.45K	USD	Annual
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax`	$-38.39K	USD	Annual
Shares issued for cashless exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	-	USD	Annual
Begining balance, shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	-	shares	Annual
Begining balance, shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	140,992.00	shares	Annual
Shares issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$100.00K	USD	Annual
Begining balance, shares	`StockIssuedDuringPeriodSharesIssuedForServices`	43,264.00	shares	Annual
Repurchase of common shares	`StockRepurchasedDuringPeriodValue`	$99.96K	USD	Annual
Ending balance, value	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-4.73M	USD	Point-in-time
Ending balance, value	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.16M	USD	Point-in-time
Ending balance, value	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$17.99M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.